Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 1.98B | £ 1.48B | £ 1.84B | £ 1.67B | £ 1.48B |
Total Assets | £ 18.75B | £ 15.24B | £ 14.87B | £ 13.97B | £ 14.73B |
Total Debt | £ 4.88B | £ 4.03B | £ 4.48B | £ 4.43B | £ 4.72B |
Net Debt | £ 2.89B | £ 2.55B | £ 2.64B | £ 2.76B | £ 3.24B |
Total Liabilities | £ 12.84B | £ 9.85B | £ 9.95B | £ 9.36B | £ 9.92B |
Stockholders Equity | £ 5.87B | £ 5.36B | £ 4.89B | £ 4.58B | £ 4.79B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |